Advantage Alpha Capital Partners’s Arcturus Therapeutics ARCT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-27,040	Closed	-$658K	–	170
2024 Q2	$658K	Sell	27,040 -2,841	-10%	-$69.2K	0.14%	93
2024 Q1	$1.01M	Sell	29,881 -20,643	-41%	-$697K	0.19%	102
2023 Q4	$1.59M	Buy	+50,524	New	+$1.59M	0.3%	86